Fortin; Daniel
Patent Applications and Registrations
Patent applications and USPTO patent grants for Fortin; Daniel.The latest application filed is for "luminaire connection systems".
- Fortin; Daniel - New Westminster CA
- Fortin; Daniel - Quebec CA
- Fortin; Daniel - Rosemere CA
- Fortin; Daniel - Montreal CA
- Fortin, Daniel - Rock Forest CA
- Fortin, Daniel - Verdun CA
| Patent | Date |
|---|---|
| Luminaire Grant D889,027 - Santoro , et al. | 2020-06-30 |
| Luminaire Grant D889,028 - Santoro , et al. | 2020-06-30 |
| Luminaire Grant D889,026 - Santoro , et al. | 2020-06-30 |
| Luminaire Grant D877,968 - Santoro , et al. | 2020-03-10 |
| Luminaire Grant D877,969 - Santoro , et al. | 2020-03-10 |
| Luminaire connection systems Grant 10,077,891 - Fortin September 18, 2 | 2018-09-18 |
| Luminaire Connection Systems App 20160369985 - FORTIN; Daniel | 2016-12-22 |
| Optical assembly for an end cap of a lighting fixture Grant 9,121,584 - Santoro , et al. September 1, 2 | 2015-09-01 |
| Optical Assembly For An End Cap Of A Lighting Fixture App 20140321121 - Santoro; Scott ; et al. | 2014-10-30 |
| Spatially-defined macrocycles incorporating peptide bond surrogates Grant 8,557,765 - Deslongchamps , et al. October 15, 2 | 2013-10-15 |
| Purine derivatives and their use for treatment of autoimmune diseases Grant 8,080,555 - Zacharie , et al. December 20, 2 | 2011-12-20 |
| Spatially-defined macrocyclic compounds useful for drug discovery Grant 8,022,252 - Deslongchamps , et al. September 20, 2 | 2011-09-20 |
| Triazine dimers for the treatment of autoimmune diseases Grant 7,683,061 - Penney , et al. March 23, 2 | 2010-03-23 |
| Spatially-defined Macrocycles Incorporating Peptide Bond Surrogates App 20090312540 - Deslongchamps; Pierre ; et al. | 2009-12-17 |
| Spatially-defined macrocycles incorporating peptide bond surrogates Grant 7,550,431 - Deslongchamps , et al. June 23, 2 | 2009-06-23 |
| Spatially-defined Macrocyclic Compounds Useful For Drug Discovery App 20090137817 - Deslongchamps; Pierre ; et al. | 2009-05-28 |
| 2,4,6-triamino-s-triazine-based compounds which bind to the tail (fc) portion of immunoglobulins and their use App 20090068169 - Penney; Christopher ; et al. | 2009-03-12 |
| Purine derivatives and their use for treatment of autoimmune diseases App 20090042768 - Zacharie; Boulos ; et al. | 2009-02-12 |
| Conformationally-controlled biologically active macrocyclic small molecules as motilin antagonists or ghrelin agonists Grant 7,452,862 - Deslongchamps , et al. November 18, 2 | 2008-11-18 |
| Triazine dimers for the treatment of autoimmune diseases App 20070149528 - Penney; Christopher ; et al. | 2007-06-28 |
| Spatially-defined macrocyclic compounds useful for drug discovery App 20050137127 - Deslongchamps, Pierre ; et al. | 2005-06-23 |
| Spatially-defined macrocycles incorporating peptide bond surrogates App 20050119169 - Deslongchamps, Pierre ; et al. | 2005-06-02 |
| Process of coloring concrete with a dosing system similar to a syringe for liquid colors App 20030234461 - Fortin, Daniel ; et al. | 2003-12-25 |
| Method for removal of dental cement App 20030129566 - Pameijer, Cornelis ; et al. | 2003-07-10 |
| Method for removal of dental cement App 20010031447 - Pameijer, Cornelis ; et al. | 2001-10-18 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 